Item 7. Management’s Discussion and Analysis
ITEM
7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Management’s
Discussion and Analysis of Financial Condition and Results of Operations
The
following discussion is intended to assist in understanding our business and the results of our operations. It should be read in conjunction
with the Consolidated Financial Statements and the related footnotes and “Risk Factors” that appear elsewhere in this Report.
Certain statements in this Report constitute “forward-looking statements.” Such forward-looking statements involve known
and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different
from any future results, performance or achievements expressed or implied by such forward-looking statements. Factors that might cause
such a difference include, among others, uncertainties relating to general economic and business conditions; industry trends; changes
in demand for our products and services; uncertainties relating to customer plans and commitments and the timing of orders received from
customers; announcements or changes in our pricing policies or that of our competitors; unanticipated delays in the development, market
acceptance or installation of our products and services; changes in government regulations; availability of management and other key
personnel; availability, terms and deployment of capital; relationships with third-party equipment suppliers; and worldwide political
stability and economic growth. The words “believe,” “expect,” “anticipate,” “intend”
and “plan” and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance
on these forward-looking statements, which speak only as of the date the statement was made. Unless the context requires otherwise, when
we refer to “we,” “us” and “our,” we are describing SEER and its consolidated subsidiaries on a consolidated
basis.
Overview
SEER
was formed as a publicly traded company in early 2008 through a reverse merger. SEER is dedicated to assembling complementary service
and environmental, clean-technology businesses that provide safe, innovative, cost effective, and profitable solutions in the oil &
gas, environmental, waste management and renewable energy industries. SEER currently operates four companies with its headquarters in
Broomfield, Colorado. Through its operating companies, SEER provides environmental products and solutions throughout North America. SEER’s
operating companies are discussed in more detail below. The Company also has non-controlling interests in joint ventures, some of which
have no or minimal operations.
The
Company’s domestic strategy is to grow internally through SEER’s subsidiaries that have well-established revenue streams
and, simultaneously, establish long-term alliances with and/or acquire complementary domestic businesses in rapidly growing markets for
renewable energy, waste management/treatment, emissions capture and conditioning, and environmental soil amendments and organic The focus
of the SEER family of companies, however, is to increase margins by securing or developing proprietary patented and patent-pending technologies
and then leveraging its 25 plus-year service experience to place these innovations and solutions into the growing markets of renewable
biogas, emission capture and control, renewable “green gas” capture and sale, organic soil amendments and fertilizers, as
well as general solid waste and medical/pharmaceutical waste destruction. Many of SEER’s current operating companies share customer
bases and each provides synergistic services, technologies and products.
20
Financial
Condition
As
of December 31, 2024, we had approximately $13.3 million in negative working capital, which represents a decrease of approximately $1.7
million from $11.6 million in negative working capital as of December 31, 2023. The primary reason for that working capital deficit increase
from December 31, 2023 to December 31, 2024, is due an increase in accrued liabilities, short term borrowings, and contract liabilities,
offset by an increase in cash, and accounts receivable.
As
shown in the accompanying consolidated financial statements, we have experienced recurring losses, and has accumulated a deficit of approximately
$36.2 million as of December 31, 2024, and $34.4 million as of December 31, 2023. For the years ended December 31, 2024 and 2023, respectively,
we incurred net losses of approximately $1.8 million and $2.4 million.
Realization
of a major portion of our assets as of December 31, 2024, is dependent upon our continued operations. The Company is dependent on generating
additional revenue or obtaining adequate capital to fund operating losses until it becomes profitable. In addition, we have undertaken
a number of specific steps to continue to operate as a going concern. We continue to focus on developing organic growth in our operating
companies, diversifying our service customer base and market concentrations and improving gross and net margins through increased attention
to pricing, aggressive cost management and overhead reductions, including discontinuing a line of business with insufficient margins.
Critical to achieving profitability will be our ability to license and or sell, permit and operate through our joint ventures and licensees
our CoronaLux™ waste destruction units. We have increased our business development efforts to address opportunities identified
in expanding domestic markets attributable to increased federal and state emission control regulations and a growing demand for energy
conservation and renewable energies. In addition, the Company is evaluating various forms of financing that may be available to it. There
can be no assurance that the Company will secure additional financing for working capital on favorable terms or at all, increase revenues
and achieve the desired result of net income and positive cash flow from operations in future years. These financial statements do not
give any effect to any adjustments that would be necessary should the Company be unable to report on a going concern basis.
Results
of Continuing Operations for the Years Ended December 31, 2024, and 2023
Total
revenues were $4.3 million and $2.9 million for the years ended December 31, 2024, and 2023, respectively. The increase of approximately
$1.4 million or 49% in revenues comparing the year ended December 31, 2024, to the year ended December 31, 2023, is attributable to the
increases in revenues from our products revenue of 41% and our media sales revenue of 41% from December 31 2023. Our revenue recognized over time using a measure of progress increased due to several material projects being postponed due to site preparation delays and capital constraints of
the Company in FY 2023. Media sales have also increased, as the Company’s capital constraints have slowed our ability to produce
media and fill orders in FY 2023 was relieved to some degree in 2024. We cannot assure conditions will continue to improve, but we believe
FY 2023 was an anomalous year with these slowdowns and constraints.
Operating
expenses, which include cost of products, general and administrative (G&A) expenses, salaries and related expenses, and impairment
were approximately $5.3 million and $4.6 million for the years ended December 31, 2024, and 2023. Product costs increased approximately
$0.9 million for the year ended December 31, 2024, compared to the year ended December 31, 2023 due to above revenue recognized over time using a measure of progress increased, as well as cost of media delivered. Expense due to impairment decreased $0.2 million offsetting the increase
in product costs.
Total
non-operating income or expense, net was $0.8 million of other expense for the year ended December 31, 2024, compared to $0.9 million
of other income for the year ended December 31, 2023. During the year ended December 31, 2024, the Company incurred interest expense
of $0.9 million, which was consistent with the year ended December 31, 2023. The Company also recognized approximately $0.2 million during
the year ended December 31, 2024, a result of selling equity units the Company owned in Biochar Now, LLC, which was $0 for the year ended
December 31, 2023.
There
is no provision for income taxes for both the years ended December 31, 2024, and 2023, due to our net operating loss carryforward for
both periods and we continue to maintain full valuation allowances covering our net deferred tax benefits as of December 31, 2024, and
2023.
21
Net
loss, before discontinued operations and non-controlling interest, for the year ended December 31, 2024, was $1.8 million compared to
$2.5 million for the year ended December 31, 2023. The net loss attributable to SEER after deducting $4,500 for the non-controlling interest
and adding a gain from discontinued operations of $3,700 was $1.8 million for the year ended December 31, 2024, as compared to net income
attributable to SEER after deducting $7,700 for the non-controlling interest and deducting a loss from discontinued operations of $0.2
million was $2.4 million for the year ended December 31, 2023.
Liquidity
and Capital Resources
The
following table summarizes the net cash provided by (used in) operating, investing and financing activities for the periods indicated:
Years Ended
December 31,
2024
2023
Operating activities
$ (436,100 )
$ (937,500 )
Investing activities
36,800
323,600
Financing activities
$ 878,500
$ 650,300
Operating
Activities
Net
cash used in operating activities during the year ended December 31, 2024, was $0.4 million compared to $0.9 million during the year
ended December 31, 2023. Cash used in operating activities is driven by our net loss and adjusted by non-cash items and changes in operating
assets and liabilities. Non-cash adjustments primarily include depreciation and amortization of property & equipment and intangible
assets, share based payments, gain/loss on sale off fixed assets, including assets held for sale, impairment loss, and bad debt expense/recovery.
In 2024, net non-cash adjustments totaled approximately $0.2 million and in 2023, net non-cash adjustments totaled ($0.1) million. In
2024 non-cash adjustments included $0.1 million related to share-based payments, relating to the issuance of Preferred Shares for consulting
services. In 2023 non-cash adjustments included $0.2 million related to impairment loss, gain on assets held for sale of approximately
($0.2), and $0.1 million related to bad debt adjustment.
In
addition to the non-cash adjustments to net income, changes in assets and liabilities include: a) changes in accounts payable, accrued liabilities, and customer deposits provided
$1.1 million in cash in 2024, compared to providing $0.7 million in 2023, a net increase in cash provided of $0.4 million, b) changes
in accounts receivable used $0.3 million in cash in 2024, compared to cash providing of $0.5 million in 2023, a net decrease in cash
provided of $0.8 million, c) changes in contract assets provided $17,000 in 2024, compared to providing $0.1 million in 2023, a net decrease
in cash provided of $0.1 million, d) deferred revenue used $22,700 in 2024, compared to providing $43,300 in 2023, a net decrease in
cash provided of $0.1 million.
Investing
activities
Net
cash used by investing activities is primarily attributable to the purchase of property and equipment, and proceeds from the sale of
assets, including assets held for sale. Our net cash flow provided by investing activities was $36,800 for the year ended December 31,
2024 and provided $0.3 million for the year ended December 31, 2023. During 2024 and 2023, we had proceeds of $0.1 and $0.3 million from
the sale of assets held for sale, respectively. Purchase of property, plant and equipment was $22,700 and $14,900 for the years ended
December 31, 2024 and 2023, respectively.
Financing
Activities
Net
cash provided by financing activities was approximately $0.9 million for 2024 and approximately $0.7 million for 2023. Proceeds from
the issuance of short-term and long-term debt, was $1.2 million and $0.9 million in 2024 and 2023, respectively. Payments on notes payable
were $0.3 million in 2024 and $0.2 million in 2023.
22
Critical
Accounting Policies, Judgments and Estimates
Use
of Estimates
The
preparation of these consolidated financial statements in conformity with accounting principles generally accepted in the United States
(U.S. GAAP) requires management to make a number of estimates and assumptions related to the reported amount of assets and liabilities
and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts
of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the forecasted cash flows
used in the impairment testing of goodwill and intangible assets, valuation allowances and reserves for receivables; revenue recognition
related to contracts accounted for under the percentage of completion method; and the Company’s ability to continue as a going
concern. Actual results could differ from those estimates.
Accounts
Receivable and Concentration of Credit Risk
Accounts
receivable are recorded at the invoiced amounts less an allowance for doubtful accounts and do not bear interest. The allowance for doubtful
accounts is based on our estimate of the amount of probable credit losses in our accounts receivable. We determine the allowance for
doubtful accounts based upon an aging of accounts receivable, historical experience and management judgment. Accounts receivable balances
are reviewed individually for collectability, and balances are charged off against the allowance when we determine that the potential
for recovery is remote. An allowance for doubtful accounts of approximately $24,200 have been reserved as of both December 31, 2024,
and 2023.
We
are exposed to credit risk in the normal course of business, primarily related to accounts receivable. Our customers operate primarily
in the rail transport, biogas generating and wastewater treatment industries in the United States. Accordingly, we are affected by the
economic conditions in these industries as well as general economic conditions in the United States. To limit credit risk, management
periodically reviews and evaluates the financial condition of its customers and maintains an allowance for doubtful accounts. As of December
31, 2024, and 2023, we do not believe that we have significant credit risk.
Intangible Assets
Intangible
Assets. Intangible assets deemed to have finite lives are amortized on a straight-line basis over their estimated useful lives, where
the useful life is the period over which the asset is expected to contribute directly, or indirectly, to our future cash flows. Intangible
assets are reviewed for impairment on an interim basis when certain events or circumstances exist. For amortizable intangible assets,
impairment exists when the carrying amount of the intangible asset exceeds its fair value. At least annually, the remaining useful life
is evaluated. An intangible asset with an indefinite useful life is not amortized but assessed for impairment annually, or more frequently,
when events or changes in circumstances occur indicating that it is more likely than not that the indefinite-lived asset is impaired.
Impairment exists when the carrying amount exceeds its fair value. In testing for impairment, the Company has the option to first perform
a qualitative assessment to determine whether it is more likely than not that an impairment exists. If it is determined that it is not
more likely than not that an impairment exists, a quantitative impairment test is not necessary. If the Company concludes otherwise,
it is required to perform a quantitative impairment test. To the extent an impairment loss is recognized, the loss establishes the new
cost basis of the asset that is amortized over the remaining useful life of that asset, if any. Subsequent reversal of impairment losses
is not permitted.
23
In
2022, we early adopted ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment ,
which eliminates the two-step goodwill impairment process. Goodwill is first qualitatively assessed to determine whether further impairment
testing is necessary. Factors that management considers in this assessment include macroeconomic conditions, industry and market considerations,
overall financial performance (both current and projected), changes in management and strategy, and changes in the composition or carrying
amount of net assets. If this qualitative assessment indicates that it is more likely than not that the fair value of a reporting unit
is less than its carrying amount, a one-step test is then performed by comparing the fair value of a reporting unit to its carrying amount.
If the fair value of a reporting unit is less than its carrying value, an impairment charge will be recorded for the difference between
the fair value and carrying value, but is limited to the carrying value of the reporting unit’s goodwill. This impairment loss
is included in discontinued operations in this report for fiscal year 2022. An impairment loss was charged to investments in the amount
of $182,200 for the year ended December 31, 2023.
Revenue
Recognition
In
May 2014, the FASB issued guidance on revenue from contracts with customers that superseded most current revenue recognition guidance,
including industry-specific guidance. The underlying principle of the guidance is to recognize revenue to depict the transfer of goods
or services to customers at an amount to which the company expects to be entitled in exchange for those goods or services. The new guidance
requires an evaluation of revenue arrangements with customers following a five-step approach: (1) identify the contract with a customer;
(2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to
the performance obligations; and (5) recognize revenue when (or as) the company satisfies each performance obligation. Revenues are recognized
when control of the promised services are transferred to the customers in an amount that reflects the expected consideration in exchange
for those services. A customer obtains control when it has the ability to direct the use of and obtain the benefits from the services.
Other major provisions of the guidance include capitalization of certain contract costs, consideration of the time value of money in
the transaction price and allowing estimates of variable consideration to be recognized before contingencies are resolved in certain
circumstances. The guidance also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of revenue and cash
flows arising from contracts with customers.
ITEM
7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Not
Applicable
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.